<DOC>
	<DOCNO>NCT00450086</DOCNO>
	<brief_summary>The purpose study determine whether budesonide mesalazine active treatment collagenous colitis .</brief_summary>
	<brief_title>Budesonide Capsules vs. Mesalazine Granules v . Placebo Collagenous Colitis</brief_title>
	<detailed_description>This study check reproducibility result report trial budesonide patient collagenous colitis . Efficacy mesalazine never test collagenous colitis placebo-controlled trial . This trial check superiority mesalazine placebo use common clinical symptom collagenous colitis , chronic recurrent non-bloody , watery diarrhea .</detailed_description>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Colitis , Collagenous</mesh_term>
	<mesh_term>Mesalamine</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Inclusion Criteria ( main ) : &gt; 4 watery/soft stool least 4 day week prior baseline &gt; 3 stool per day average within last 7 day prior baseline Symptoms ( chronic watery diarrhea ) least 3 month baseline Complete colonoscopy within last 12 week baseline Histologically confirm diagnosis collagenous colitis Evidence infectious diarrhea Celiac disease Endoscopichistologic finding , may cause diarrhea History partial colonic resection Diarrhea result presence symptomatic organic disease gastrointestinal tract Active colorectal cancer history colorectal cancer Severe comorbidity substantially reduce life expectancy Abnormal hepatic function liver cirrhosis ( ALT , AST AP &gt; = 2 x ULN ) Abnormal renal function ( Cystatin C &gt; ULN ) Active peptic ulcer disease , local intestinal infection Asthma , diabetes mellitus , infection , osteoporosis , glaucoma , cataract , cardiovascular disease careful medical monitoring ensure Hemorrhagic diathesis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>